Toggle navigation
Home
Menu
Phenotypes
Genotypes
Strains
Panels, Populations
QTL Archive
Protocols
Contributors
Phenotyping procedures
Behavior tests
Drug and diet studies
Pathogen and challenge studies
Ontologies
Aging studies
Molecular studies
Replicability analysis
Multi-measure study designs
What's new
Submit data
Downloads
MPD data API
Data changelog
Tools demo
About
MyMPD
My Collection
Sign In / Register
Search
Examples
Phenotype measures in
CSNA03
associated with
ontology
term
VT:0010455 'rhythmic behavior trait'
List measures from all projects
Broaden
Navigate ontologies
Filter Table Results
Data set
Clear All
CSNA03
(10)
Procedure / Protocol
Clear All
in vitro assay
(10)
Treatment
Clear All
(none)
(10)
Panel
Clear All
CC w/par
(5)
inbred w/CC8
(5)
Sex
Clear All
both
(10)
Help / filtering
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
CSNA03:685
CSNA03
in vitro assay
(none)
peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders [h]
period_in
112539
inbred w/CC8
8
both
8-12wks
N=9
2020
CSNA03:686
CSNA03
in vitro assay
(none)
peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC [h]
period_cc
112544
CC w/par
40
both
8-12wks
N=4
2020
CSNA03:688
CSNA03
in vitro assay
(none)
specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders [n]
phase_in
112540
inbred w/CC8
8
both
8-12wks
N=9
2020
CSNA03:689
CSNA03
in vitro assay
(none)
specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC [n]
phase_cc
112545
CC w/par
40
both
8-12wks
N=4
2020
CSNA03:691
CSNA03
in vitro assay
(none)
peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders [n/s]
amplitude_in
112541
inbred w/CC8
8
both
8-12wks
N=9
2020
CSNA03:692
CSNA03
in vitro assay
(none)
peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s]
amplitude_cc
112546
CC w/par
40
both
8-12wks
N=4
2020
CSNA03:694
CSNA03
in vitro assay
(none)
number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders [days]
damping_in
112542
inbred w/CC8
8
both
8-12wks
N=9
2020
CSNA03:695
CSNA03
in vitro assay
(none)
number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC [days]
damping_cc
112547
CC w/par
40
both
8-12wks
N=4
2020
CSNA03:697
CSNA03
in vitro assay
(none)
percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, founders [%]
goodness_of_fit_in
112543
inbred w/CC8
8
both
8-12wks
N=9
2020
CSNA03:698
CSNA03
in vitro assay
(none)
percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, CC [%]
goodness_of_fit_cc
112548
CC w/par
40
both
8-12wks
N=4
2020
All boxes
Work with selected measures
Or, add these measures to your collection.
no folder
put them in new folder
FUNDING
CITING MPD
UNITS
CHANGE LOG
CONTACT
HELP | FEEDBACK
TERMS OF USE | PRIVACY POLICY
RESEARCH RESOURCES
MOUSE GENOME INFORMATICS
© 2001-2024 THE JACKSON LABORATORY
